USPTO serial 87465341
SIMPLY CSL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- VAGHANI, MAYUR C
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SIMPLY CSL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
King of Prussia, PA
King of Prussia, PA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow Smith, Gambrell & Russell, LLP1055 Thomas Jefferson St. NW, Suite 400Washington, DC 20007UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable audio files, multimedia files, text files, e-mails, written documents, audio material video material and games featuring information in the form of downloadable educational/training communications in the fields of in the field of illnesses, diseases and health-related and medical therapies, human resource development for the promotion of employee retention, career growth, and increased productivity for employees and employers | ACTIVE | — |
| 016 | Printed matter and publications, namely, printed instructional material and magazines featuring pharmaceutical products, vaccines, blood, blood products, bleeding disorders, blood fractionations, rhesus prophylaxis and human autoimmune disorders; printed instructional and teaching materials in the field of pharmaceutical products, vaccines, blood, blood products, bleeding disorders, blood fractionations, rhesus prophylaxis and human autoimmune disorders; brochures, pamphlets and informational flyers in the field of pharmaceutical products, vaccines, blood, blood products, bleeding disorders, blood fractionations, rhesus prophylaxis and human autoimmune disorders; posters; stationery | ACTIVE | — |
| 036 | Processing, administration and managing employee benefit plans and employee welfare benefit plans concerning insurance and finance; Providing information in the field of employee financial benefit plans | ACTIVE | — |
| 041 | Providing continuing medical education courses; arranging and conducting of educational conferences in the field of health care and medical therapies; development and dissemination of printed educational materials of others in the field of health care and medical therapies; publication of educational and training guides in the field of health care and medical therapies; providing educational courses in the field of diet and health care; Educational services, namely, arranging and conducting classes, seminars, conferences, workshops, in the field of health-related and medical therapies and related business education programs and distribution of training material in connection therewith; Educational services, namely, providing a learning and innovation center featuring customized leadership, motivational, educational, and brainstorming training in the field of health care and medical therapies; Business education and training services, namely, developing customized and customized in-company leadership and executive development programs, providing executive coaching services, providing business education programs to employees and executives, and providing public and in-company keynote presentations to business leaders in the field of health care and medical therapies; Educational and entertainment services, namely, providing motivational and educational speakers in the field of health care and medical therapies, and speakers in the field of self- and personal improvement | ACTIVE | — |
| 042 | Providing scientific information in the field of health care and medical therapies; scientific information services in the field of health care and medical therapies provided via the Internet; providing research information on donation of human blood for medical research; providing medical and scientific research information about the results of clinical trials for pharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CSL Behring L.L.C.
- Other trademarks owned by CSL Behring L.L.C.
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named SIMPLY CSL
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 11, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 11, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 16, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 15, 2021 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Nov 8, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 4, 2021 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 4, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 6, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 4, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| May 4, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| May 4, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 6, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 4, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Nov 4, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 4, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 4, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 2, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 2, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 2, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 13, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 11, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Nov 11, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Nov 11, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 4, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 26, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 26, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 9, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 20, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 15, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 15, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 15, 2019 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 15, 2019 | ALIE | ASSIGNED TO LIE | — |
| Feb 11, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 17, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 17, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 23, 2018 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Aug 23, 2018 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Aug 23, 2018 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Feb 13, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 13, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 13, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 24, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 24, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 22, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jan 5, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 19, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 2, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 30, 2017 | NWAP | NEW APPLICATION ENTERED | — |